RxDoctor Payments Data

Laurie Glimcher

Rheumatology · New York, NYNPI 1952351488

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $3,871,279 of the $3,871,502 with a category attached, or 100.0%. 4 manufacturers reported payments, led by Bristol Myers Squibb at 56.7% of the total. Reporting peaked in 2019 at $1,176,597 and has fallen 100.0% since, to $93 in 2024. Among rheumatology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,871,502in general payments, 2019–2025

Across 23 payments — averaging $168,326 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bristol Myers Squibb$2.2M
  • GSK$887K
  • E.r. Squibb & Sons, L.L.C.$791K
  • Vertex$93

What the payments were for

  • Speaking & faculty fees$3,871,279100%
  • Food & beverage$1300%
  • Gifts$930%

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bristol Myers Squibb12$2,193,860
GSK5$887,018
E.r. Squibb & Sons, L.L.C.4$790,532
Vertex2$93

How this compares

$3,871,502 in reported general payments places this provider in the 95th percentile of 541 rheumatology providers in New York.

See all rheumatology providers in New York

Other rheumatology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →